Dr. Priscilla Callahan-Lyon is an internist and pulmonologist. After 20 years of private medical practice, she joined FDA in 2008 as a medical reviewer in the over-the-counter division of the Center for Drug Evaluation and Research where she worked extensively on nicotine replacement therapies. She moved to the Office of Science in the Center for Tobacco Products (CTP) in 2012. While in the Office of Science, Dr. Callahan served as Technical Project Lead for the IQOS Premarket Tobacco Product Application as well as the program lead for the Investigational Tobacco Products program. She represents CTP on several FDA and Agency-wide initiatives including the Nicotine Steering Committee, the HHS Tobacco Control Steering Committee and the HHS Tobacco Cessation Workgroup. Currently Dr. Callahan serves as Senior Science Advisor in the Office of the Center Director for CTP. In this position, she works with CTP leadership to provide scientific input and expertise on policy and regulatory matters and to continue CTP's efforts to make tobacco-related death and disease part of America's past, not America's future.
Treating Smoking in Vascular Patients: An Essential Component of Care
Wednesday, June 14, 2023
10:08 AM – 10:28 AM ET